ATR logo

AptarGroup (ATR)

Profile

Full Name

AptarGroup, Inc.

Ticker Symbol

ATR

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

April 23, 1993

Indexes

Not included

Website

http://www.aptar.com

Employees

13500

Key Details

Price

$143.94(-1.27%)

Market cap

$9.57B(Mid cap)

Last Dividend

$0.45

TTM Dividend yield

1.22%

Annual revenue

$3.58B(+2.74% YoY)

Annual EPS

$5.53(+30.12% YoY)

PE ratio

25.98

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$143.94
ATR price is $143.94

30-Day Relative Volume

0.69
ATR 30-day relative volume is 0.69

Price Performance

Price Most recent change

-1.27%
ATR price was down -1.27% on Apr 15, 2025

Price YTD change

-8.38%
ATR price is down -8.38% since January 1st

Price 1-year change

+3.86%
ATR price is up +3.86% year-on-year

Price 3-year change

+22.61%
ATR price is up +22.61% over the past 3 years

Price Range

Price All-time high

$178.03
ATR price is currently -19.15% below its historical high of $178.03

Price 3-year low

$90.23
ATR price is currently +59.53% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.57B
ATR market capitalization is $9.57 billion

Market cap 3-year change

+24.47%
ATR market capitalization is up +24.47% over the past 3 years

Market cap All-time high

$11.72B
ATR market capitalization is currently -18.34% below its historical high of $11.72 billion

Market cap sector rank

92.43%
ATR market capitalization is higher than 92.43% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.45%
ATR shares outstanding is up +0.45% year-on-year

Shares Outstanding 3-Year Change

+1.52%
ATR shares outstanding is up +1.52% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.68
ATR beta is 0.68

200-day SMA

$154.59
ATR price is currently -6.89% below its 200-day simple moving average

50-day SMA

$146.51
ATR price is currently -1.75% below its 50-day simple moving average

RSI

48.17
ATR 14-day relative strength index is 48.17

Volume

0.69
ATR 30-day relative volume is 0.69

ATR

$4.86
ATR average true range is $4.86

10-day Historical Volatility

58.03%
ATR 10-day historical volatility is 58.03%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.45
ATR last dividend was $0.45 per share, with an ex-dividend date of February 5, 2025

Next Dividend

-
ATR next dividend has not yet been announced

Dividend per share

Dividend per share

$1.72
ATR annual dividend per share is $1.72

Dividend per share Sector Rank

62.79%
ATR annual dividend per share is higher than 62.79% of companies in Healthcare sector

Dividend per share 1-Year Change

+8.86%
ATR annual dividend per share is up +8.86% year-on-year

Dividend per share 3-Year Change

+14.67%
ATR annual dividend per share is up +14.67% over the past 3 years

Dividend yield

Dividend yield

1.19%
ATR annual dividend yield is 1.19%

Dividend yield Sector Rank

32.94%
ATR annual dividend yield is higher than 32.94% of companies in Healthcare sector

Other

Payout ratio

30.45%
ATR annual payout ratio is 30.45%

Dividends paid

$114.06M
ATR annual dividends paid is $114.06 million

Free cash flow

$349.22M
ATR annual free cash flow is $349.22 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.58B
ATR annual revenue is $3.58 billion

Revenue Analysts estimate

$3.65B
ATR annual revenue is currently -1.76% lower than the consensus analysts' forecast

Revenue 1-year change

+2.74%
ATR annual revenue is up +2.74% year-on-year

Revenue Sector rank

89.83%
ATR annual revenue is higher than 89.83% of companies in Healthcare sector

EPS

EPS

$5.53
ATR annual earnings per share is $5.53

EPS Analysts estimate

$5.54
ATR annual earnings per share is currently -0.18% lower than the consensus analysts' forecast

EPS 1-year change

+30.12%
ATR annual earnings per share is up +30.12% year-on-year

EPS Sector rank

96.11%
ATR annual earnings per share is higher than 96.11% of companies in Healthcare sector

Profit

Gross profit

$1.36B
ATR annual gross profit is $1.36 billion

Gross margin

37.83%
ATR annual gross profit margin is 37.83%

Operating profit

$509.50M
ATR annual operating income is $509.50 million

Operating margin

14.22%
ATR annual operating profit margin is 14.22%

Net income

$374.54M
ATR annual net profit is $374.54 million

Net margin

10.45%
ATR annual net profit margin is 10.45%

Expenses

Total expenses

$3.07B
ATR annual total expenses is $3.07 billion

Operating expenses

$846.01M
ATR annual total operating expenses is $846.01 million

Cost of goods sold

$2.23B
ATR annual cost of goods sold is $2.23 billion

Selling, general & administrative expenses

$582.23M
ATR annual SGA is $582.23 million

Depreciation and amortization

$263.78M
ATR annual depreciation & amortization is $263.78 million

Interest expense

$43.90M
ATR annual interest expense is $43.90 million

Income tax

$95.59M
ATR annual income tax is $95.59 million

EBIT & EBITDA

EBIT

$513.66M
ATR annual earnings before interest & taxes is $513.66 million

EBITDA

$777.45M
ATR annual EBITDA is $777.45 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.43B
ATR annual total assets is $4.43 billion

Non current assets

$2.95B
ATR annual long term assets is $2.95 billion

Current assets

$1.48B
ATR annual total current assets is $1.48 billion

Cash and cash equivalents

$223.84M
ATR annual cash & cash equivalents is $223.84 million

Accounts receivable

$658.06M
ATR annual accounts receivable is $658.06 million

Inventory

$461.81M
ATR annual inventory is $461.81 million

Liabilities

Total liabilities

$1.95B
ATR annual total liabilities is $1.95 billion

Long term liabilities

$878.07M
ATR annual total long term liabilities is $878.07 million

Current liabilities

$1.07B
ATR annual total current liabilities is $1.07 billion

Accounts payable

$295.97M
ATR annual accounts payable is $295.97 million

Debt

Total debt

$1.08B
ATR annual total debt is $1.08 billion

Total debt 1-year change

-9.17%
ATR annual total debt is down -9.17% year-on-year

Long term debt

$737.78M
ATR annual long term debt is $737.78 million

Short term debt

$338.29M
ATR annual short term debt is $338.29 million

Equity & Capital

Shareholders equity

$2.47B
ATR annual stockholders equity is $2.47 billion

Book value

$2.47B
ATR annual book value is $2.47 billion

Retained earnings

$2.37B
ATR annual retained earnings is $2.37 billion

Working capital

$410.10M
ATR annual working capital is $410.10 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$643.41M
ATR annual cash flow from operations is $643.41 million

Cash from operations 1-year change

+11.85%
ATR annual cash flow from operations is up +11.85% year-on-year

Cash from investing

-$396.72M
ATR annual cash flow from investing activities is -$396.72 million

Cash from investing 1-year change

-22.27%
ATR annual cash flow from investing activities is down -22.27% year-on-year

Cash from financing

-$225.34M
ATR annual cash flow from financing activities is -$225.34 million

Cash from financing 1-year change

-31.35%
ATR annual cash flow from financing activities is down -31.35% year-on-year

CAPEX

CAPEX

$294.19M
ATR annual capital expenditures is $294.19 million

CAPEX 1-year change

-7.6%
ATR annual capital expenditures is down -7.6% year-on-year

Free Cash Flow

Free cash flow

$349.22M
ATR annual free cash flow is $349.22 million

Free cash flow 1-year change

+35.97%
ATR annual free cash flow is up +35.97% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

37.83%
ATR annual gross profit margin is 37.83%

Operating margin

14.22%
ATR annual operating profit margin is 14.22%

Net margin

10.45%
ATR annual net profit margin is 10.45%

ROA & ROE

ROA

8.43%
ATR annual return on assets is 8.43%

ROE

15.58%
ATR annual return on equity is 15.58%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

25.98
ATR price to earnings ratio is 25.98

PE ratio Sector rank

53.92%
ATR price to earnings ratio is higher than 53.92% of companies in Healthcare sector

PB Ratio

PB ratio

3.87
ATR price to book ratio is 3.87

PB ratio Sector rank

78.27%
ATR price to book ratio is higher than 78.27% of companies in Healthcare sector

PS Ratio

PS ratio

2.67
ATR price to sales ratio is 2.67

PS ratio Sector rank

49.36%
ATR price to sales ratio is higher than 49.36% of companies in Healthcare sector

Enterprise value

Enterprise value

$10.42B
ATR enterprise value is $10.42 billion

Enterprise value Sector rank

92.47%
ATR enterprise value is higher than 92.47% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

13.41
ATR EV/EBITDA is 13.41

EV/EBITDA Sector rank

86.25%
ATR EV/EBITDA is higher than 86.25% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.38
ATR annual current ratio is 1.38

Quick ratio

0.95
ATR annual quick ratio is 0.95

Leverage

Debt to equity

0.42
ATR annual debt to equity ratio is 0.42

Interest coverage ratio

11.70
ATR annual interest coverage ratio is 11.70

Risk & Stability

Piotroski F-Score

6
ATR piotroski f-score is 6

Altman Z-Score

5.00
ATR altman z-score is 5.00

Analyst ratings

Recent major analysts updates

Feb 10, 25 Wells Fargo
Overweight
Feb 10, 25 Raymond James
Outperform
Feb 10, 25 Baird
Outperform
Jan 7, 25 Raymond James
Outperform
Jan 6, 25 Wells Fargo
Overweight
Oct 28, 24 Baird
Outperform
Oct 15, 24 Wells Fargo
Overweight
Oct 14, 24 Jefferies
Buy
Jul 17, 24 Wells Fargo
Overweight
Apr 29, 24 William Blair
Outperform

Institutional Ownership

Similar stocks

NBIX logo
Neurocrine Biosciences (NBIX)
WBA logo
Walgreens Boots Alliance (WBA)
MEDP logo
Medpace Holdings (MEDP)
ASND logo
Ascendis Pharma A/S (ASND)
GMED logo
Globus Medical (GMED)
DOCS logo
Doximity (DOCS)
MRNA logo
Moderna (MRNA)
QGEN logo
Qiagen NV (QGEN)
VTRS logo
Viatris (VTRS)
  • What is the ticker symbol for AptarGroup?
  • Does AptarGroup pay dividends?
  • What sector is AptarGroup in?
  • What industry is AptarGroup in?
  • What country is AptarGroup based in?
  • When did AptarGroup go public?
  • Is AptarGroup in the S&P 500?
  • Is AptarGroup in the NASDAQ 100?
  • Is AptarGroup in the Dow Jones?
  • When was AptarGroup's last earnings report?
  • When does AptarGroup report earnings?
  • Should I buy AptarGroup stock now?

What is the ticker symbol for AptarGroup?

The ticker symbol for AptarGroup is NYSE:ATR

Does AptarGroup pay dividends?

Yes, AptarGroup pays dividends. The last payment was $0.45, with an ex-dividend date on February 5, 2025

What sector is AptarGroup in?

AptarGroup is in the Healthcare sector

What industry is AptarGroup in?

AptarGroup is in the Medical Instruments & Supplies industry

What country is AptarGroup based in?

AptarGroup is headquartered in United States

When did AptarGroup go public?

AptarGroup's initial public offering (IPO) was on April 23, 1993

Is AptarGroup in the S&P 500?

No, AptarGroup is not included in the S&P 500 index

Is AptarGroup in the NASDAQ 100?

No, AptarGroup is not included in the NASDAQ 100 index

Is AptarGroup in the Dow Jones?

No, AptarGroup is not included in the Dow Jones index

When was AptarGroup's last earnings report?

AptarGroup's most recent earnings report was on Feb 7, 2025

When does AptarGroup report earnings?

The next expected earnings date for AptarGroup is May 1, 2025

Should I buy AptarGroup stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page